{"id":140687,"title":"Archived 43: Summary: First booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age recommendations: NACI statement August 19, 2022 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T14:13:49.663000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-first-booster-dose-pfizer-biontech-comirnaty-covid-19-vaccine-children-5-11-years/summary-august-19-2022.html?wbdisable=true","snippet":"Archived 43: Summary: First booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age recommendations: NACI statement August 19, 2022 - Canada.ca Skip to main content Skip to \"About government\" We have archived this page and will not be updating…","rawSnapshotUrl":"/api/snapshots/raw/140687","browseUrl":"https://replay.healtharchive.ca/job-1/20250418141349/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-first-booster-dose-pfizer-biontech-comirnaty-covid-19-vaccine-children-5-11-years/summary-august-19-2022.html?wbdisable=true#ha_snapshot=140687","mimeType":"text/html","statusCode":200}